<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://www.theedgeresearch.com/news</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-25</news:publication_date>
      <news:title>Defying The Skeptics, The Economy Is Humming</news:title>
    </news:news>
    <lastmod>2026-10-25</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/NYT</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-25</news:publication_date>
      <news:title>ILLR EQUITY ACTION REMINDER Faruqi &amp; Faruqi, LLP Reminds Triller (ILLR) Investors of Securities Class Action Lawsuit Deadline on December 14, 2026</news:title>
    </news:news>
    <lastmod>2026-10-25</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/THCX</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-25</news:publication_date>
      <news:title>Tilray Now Sells More Beer Than Cannabis. Here&apos;s Why That Might Be Good News for Investors.</news:title>
    </news:news>
    <lastmod>2026-10-25</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/SPCX</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-25</news:publication_date>
      <news:title>Elon Musk Just Delivered Spectacular News for SpaceX Stock Investors</news:title>
    </news:news>
    <lastmod>2026-10-25</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/ABBV</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-25</news:publication_date>
      <news:title>A Worthwhile Exit Strategy</news:title>
    </news:news>
    <lastmod>2026-10-25</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/FISN</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-25</news:publication_date>
      <news:title>Deep Fission Targets 2027 Kansas Nuclear Pilot, 2028 Commercial Rollout</news:title>
    </news:news>
    <lastmod>2026-10-25</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/NFLX</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-25</news:publication_date>
      <news:title>Netflix Is Shaking Up Its Content Leadership. Here&apos;s What Needs to Happen Next.</news:title>
    </news:news>
    <lastmod>2026-10-25</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/GOOG</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-25</news:publication_date>
      <news:title>One of Google DeepMind&apos;s top execs says lifelong learners will have an edge in the AI workplace</news:title>
    </news:news>
    <lastmod>2026-10-25</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/NBP</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-25</news:publication_date>
      <news:title>NovaBridge Biosciences Reports Mature Phase 1b Data at ESMO 2026 Positioning Givastomig for Registrational Development</news:title>
    </news:news>
    <lastmod>2026-10-25</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/GMAB</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-25</news:publication_date>
      <news:title>Genmab Announces Updated Follow-Up Analyses from Phase 2 Study of Petosemtamab Demonstrate Meaningful Objective Response Rates in Patients with Metastatic Colorectal Cancer</news:title>
    </news:news>
    <lastmod>2026-10-25</lastmod>
  </url>
  <url>
    <loc>https://www.theedgeresearch.com/quote/AGEN</loc>
    <news:news>
      <news:publication>
        <news:name>TheEdgeResearch</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-25</news:publication_date>
      <news:title>Agenus Reports 72% of Patients with Locally Advanced dMMR Colon Cancer Had No Cancer Remaining at Surgery Following Six Weeks of BOT+BAL in Phase 2 NEOASIS Study at ESMO 2026</news:title>
    </news:news>
    <lastmod>2026-10-25</lastmod>
  </url>
</urlset>
